par Scherpereel, Arnaud;Berghmans, Thierry ;Lafitte, Jean-Jacques;Colinet, Benoît;Richez, Michel;Bonduelle, Yves;Meert, Anne-Pascale ;Dhalluin, X;Leclercq, Nathalie ;Paesmans, Marianne ;Willems, Lucas ;Sculier, Jean-Paul ;European Lung Cancer Working Party (ELCWP),
Référence The European respiratory journal, 37, 1, page (129-135)
Publication Publié, 2011-01
Référence The European respiratory journal, 37, 1, page (129-135)
Publication Publié, 2011-01
Article révisé par les pairs
Titre: |
|
Auteur: | Scherpereel, Arnaud; Berghmans, Thierry; Lafitte, Jean-Jacques; Colinet, Benoît; Richez, Michel; Bonduelle, Yves; Meert, Anne-Pascale; Dhalluin, X; Leclercq, Nathalie; Paesmans, Marianne; Willems, Lucas; Sculier, Jean-Paul; European Lung Cancer Working Party (ELCWP), |
Informations sur la publication: | The European respiratory journal, 37, 1, page (129-135) |
Statut de publication: | Publié, 2011-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Chemotherapy |
Doxorubicin | |
Histone deacetylase inhibitors | |
Mesothelioma | |
Valproic acid | |
MeSH keywords: | Aged |
Aged, 80 and over | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Disease Progression | |
Disease-Free Survival | |
Doxorubicin -- administration & dosage | |
Female | |
Histone Deacetylase Inhibitors -- administration & dosage | |
Humans | |
Lung Neoplasms -- drug therapy -- mortality | |
Male | |
Mesothelioma -- drug therapy | |
Middle Aged | |
Protein Isoforms | |
Valproic Acid -- administration & dosage | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0903-1936 |
info:doi/10.1183/09031936.00037310 | |
info:pii/09031936.00037310 | |
info:scp/79251559363 | |
info:pmid/20530048 |